Citation: Ev. Gurevich et al., Thalamo-cortical afferents control transient expression of the dopamine D-3 receptor in the rat somatosensory cortex, CEREB CORT, 11(8), 2001, pp. 691-701
Citation: Jn. Joyce, D-2 but not D-3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: Influence of withdrawal period, SYNAPSE, 40(2), 2001, pp. 137-144
Citation: Jn. Joyce, Dopamine D-3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs, PHARM THERA, 90(2-3), 2001, pp. 231-259
Citation: Jn. Joyce et al., The zitter mutant rat exhibits loss of D3 receptors with degeneration of the dopamine system, NEUROREPORT, 11(10), 2000, pp. 2173-2175
Citation: Ev. Gurevich et al., Ontogeny of the dopamine D-2 receptor mRNA expressing cells in the human hippocampal formation and temporal neocortex, J CHEM NEUR, 20(3-4), 2000, pp. 307-325
Citation: Ev. Gurevich et Jn. Joyce, Dopamine D-3 receptor is selectively and transiently expressed in the developing whisker barrel cortex of the rat, J COMP NEUR, 420(1), 2000, pp. 35-51
Citation: Bs. Neal-beliveau et Jn. Joyce, Timing: A critical determinant of the functional consequences of neonatal 6-OHDA lesions, NEUROTOX T, 21(2), 1999, pp. 129-140
Citation: Ev. Gurevich et al., Developmental regulation of expression of the D-3 dopamine receptor in ratnucleus accumbens and Islands of Calleja, J PHARM EXP, 289(1), 1999, pp. 587-598
Authors:
Ma, SY
Ciliax, BJ
Stebbins, G
Jaffar, S
Joyce, JN
Cochran, EJ
Kordower, JH
Mash, DC
Levey, AI
Mufson, EJ
Citation: Sy. Ma et al., Dopamine transporter-immunoreactive neurons decrease with age in the humansubstantia nigra, J COMP NEUR, 409(1), 1999, pp. 25-37